BiotechTube
Home/Osel/Tom Parks, PhD
TP

Tom Parks, PhD

Director of Product Development

Osel

Therapeutic Areas

OncologyWomen's HealthInfectious Disease

Osel Pipeline

DrugIndicationPhase
MO-03 (CBM588)Advanced/Metastatic Renal Cell Carcinoma (in combo with IO)Phase 3
LACTIN-VRecurrent Bacterial VaginosisPhase 2
MucoCept-HIVHIV Prevention in WomenPreclinical

Leadership Team at Osel

PP
Peter P. Lee, PhD
Founder and Executive Chairman
LA
Laurel A. Lagenaur, PhD
Director of Research
View full Osel profile